| New Analysis Shows That Intensive Lipitor Therapy Cuts the Risk of ...
NEW YORK, Feb. 7 /PRNewswire-FirstCall/ -- Patients with coronary heart disease who took Lipitor(R) (atorvastatin calcium) 80 mg tablets reduced their risk of hospitalizations due to heart failure compared to patients taking the 10 mg dose of Lipitor, according to a new analysis of a subset of patients from the five-year TNT (Treating to New Targets) study, published in today's issue of Circulation. "These results show that patients with a history of heart failure who were treated with Lipitor 80 mg dose significantly reduced their chances of hospitalizations for heart failure," said Dr. Rochelle Chaiken, vice president of Pfizer's CV Metabolic group. "This important new information for physicians and patients adds to what has been shown about the cardiovascular efficacy of Lipitor in reducing the risk of events like heart attacks, strokes and revascularization procedures." The analysis showed that patients with heart disease who took Lipitor 80 mg dose achieved significant reductions in the risk of hospitalizations due to heart failure by 26 percent.
AstraZeneca cutting 3,000 jobs
AstraZeneca said Thursday it plans to cut 3,000 jobs over the next three years because of an anticipated slowdown in sales growth. Details of the job cuts were not disclosed. Based in London, the pharmaceutical giant (NYSE:AZN - News) has 65,000 employees worldwide. The company has its U.S. headquarters in Wilmington, Del., where it employs 6,000, and about 12,000 employees in the United States. The company also reported 2006 financial results Thursday that included a profit of $6 billion, a 28 percent over the previous year's earnings. AstraZeneca's lead products include Nexium, a heartburn drug ; Crestor, a treatment for high cholesterol; the schizophrenia drug Seroquel; Symbicort, an asthma therapy; and Arimidex, a breast cancer drug. Published February 1, 2007 by the Philadelphia Business Journal .
Zero tolerance: Bears must win or leave us be
As a guy just out of the hospital, I could try the perspective speech -- what doesn't kill you makes you stronger -- but you've heard that bunk before. Like last year, when Steve Smith slid down the south goalpost like a stripper. And five winters ago, when native son Donovan McNabb dunked the ball over the other crossbar. Truth be told, if the Bears lose today, it just might kill all the hope and emotion you have built up over 21 seasons of acid indigestion since ''The Super Bowl Shuffle'' stopped. There is no consolation this time. You have endured Dave Wannstedt's bad mustache and Dick Jauron's monotone. You have sat through Cade McNown, Henry Burris, Jonathan Quinn and too many other men unfit to be pro quarterbacks. You have smelled Rashaan Salaam's second-hand pot smoke, dealt with Curtis Enis' party-animal-to-Jesus mood swings and wondered if David Terrell would accumulate more parking tickets than drops.
What
According to the British medical journal The Lancet, heartburn is pretty common. In fact, 25 percent of Americans report experiencing heartburn at least once a month, 12 percent at least once per week and 5 percent daily. So what is heartburn? And what about gastroesophageal reflux disease (GERD)? Here's a guide to provide a bit more understanding of that burning sensation in your chest. Why is it called heartburn? "Heartburn is often sensed as a burning feeling behind the middle of the lower to middle of the chest, giving the sense that it may be coming from the heart," says Dr. Philip Jaffe, an associate professor of medicine at Yale University School of Medicine. What is happening, biologically speaking? According to Dr.
|
